SUBSCRIBE
SUBSCRIBE
News   Deals

Sanofi-Aventis (France) Says Holds Offer for Genzyme Corporation at $69/Share

September 27, 2010 | 
1 min read
PARIS (Reuters) - Sanofi-Aventis has not changed its offer of $69 per share for drugmaker Genzyme, a Sanofi spokesman said Monday, declining to comment on a report that the drugmaker had lined up more financing for its bid.
Mergers & acquisitions Europe
Sanofi (France)
MORE ON THIS TOPIC
Contemporary art collage of woman sitting in the lotus position, cloud, pillows against the background of the night sky. Concept of healthy lifestyle and sport. Good and relaxing sleep. Copy space.
Mergers & acquisitions
Another Bidding War Breaks as Lundbeck Bids for Sleep Biotech Avadel
November 14, 2025
 · 
1 min read
 · 
Annalee Armstrong
Investment mistakes, taxes, expenses, and unknown costs drain money, concept of Businessman carries a money bag with a big hole, banknotes falling out
Mergers & acquisitions
Merck Again Brings Out Big Bucks, Buys Cidara in $9.2B Antiviral Push
November 14, 2025
 · 
2 min read
 · 
Tristan Manalac
Shanghai.China-Feb.25th 2022: Pfizer company sign on office building. Pharmaceutical and biotechnology corporation
Mergers & acquisitions
Pfizer Closes Metsera Deal, Officially Ending Bidding War Drama
November 13, 2025
 · 
1 min read
 · 
Annalee Armstrong
Upward arrow on the background of the flag of China. Paper plane. Economic recovery. Copy space. Business. Background.
China
Recently Launched Third Arc Turns to China for Cancer T Cell Engagers
November 13, 2025
 · 
2 min read
 · 
Tristan Manalac